CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Harrow Health

For profitWebsite ↗

Also known as: HARROW EYE | Harrow Inc | Imprimis Pharmaceuticals, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Sep 1, 2008

First marketed drug

Jun 1, 1998

Last known activity

Feb 1, 2026

Timeline

1990s

  1. Jun 1, 1998

    Harrow Health— Founded

2000s

  1. Aug 19, 2005

    nepafenac— NDA Secondary Org

  2. Aug 19, 2005

    nepafenac— Marketing Organization

Drugs by trial phase (8 distinct, 7 trials)

Phase 3 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (12)

Recent trials (7)

Details

Founded
San Diego, CA, US Jun 1, 1998
Last known activity
Feb 1, 2026

Notes

formerly Imprimis Pharmaceuticals, Inc.